Angled Label Regions for Injectable Drug Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current pharmaceutical packaging systems do not effectively differentiate between injectable drug names and concentrations, which can lead to severe consequences, including patient death, due to inaccurate identification by medical professionals.

Innovation Solution

A packaging system featuring a container with a label that has distinct, angled regions for the drug name and concentration, reducing informational clutter and requiring active manipulation to separate and reveal the information, thereby enhancing visibility and clarity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If traditional label orientation (peripheral or axial alignment) is used, then the label is easy to read, but the differentiation between drug name and concentration is insufficient

Engineering Contradiction:
Improvedrug identification accuracyVSAvoidlabel readability
Core Design Contradiction:
Loss of informationVSEase of operation

Solution Approach 1:

The label is segmented into distinct angular regions, with the drug name positioned in a first angular region and the concentration in a second angular region. This segmentation allows medical professionals to quickly differentiate between critical information elements (drug identity vs. dosage) by their angular position, reducing identification errors while maintaining readability through systematic organization.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from traditional linear or peripheral label arrangements to an angular/dimensional arrangement where information is distributed around the container's circumference at specific angles. This dimensional change allows multiple pieces of information to be simultaneously accessible without overlapping, improving both differentiation and readability.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If all label information is displayed in one region, then the label is compact, but the differentiation between drug name and concentration is poor

Engineering Contradiction:
Improvedrug identification accuracyVSAvoidlabel structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The label structure is segmented into multiple functional regions positioned at different angles around the container. The drug name occupies a first angular region while the concentration occupies a second angular region, creating visual and spatial differentiation that enhances identification accuracy without requiring complex additional components.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the label are assigned different angular positions and visual characteristics appropriate to their function. Critical identification information (drug name) is placed in a distinct angular region from dosage information (concentration), allowing each region to serve its specific purpose with optimized visual properties for its intended function.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS10702452B2Packaging system and methods of alerting a practitioner
Publication Date: 2020.07.07 BAXTER INT INC
  • US10702452B2 patent drawing
  • US10702452B2 patent drawing
  • US10702452B2 patent drawing

AI summary

A packaging system includes a container having a closed end an open end, a longitudinal axis running through the closed end and the open end, and an outer surface. A closure assembly fitted to the open end of the container has an access port. The system also includes a detachable cap disposed over the access port, and a label disposed about the container, characterized in that the label has a first region angled relative to the longitudinal axis, which first region consists essentially of a name of an injectable drug product, and a second region angled relative to the longitudinal axis, which second region consists essentially of a concentration of the injectable drug product, whereby the said first and second regions are angled such as to lie in planes that make non-zero as well as non-right angles with the longitudinal axis.